Sydney Dy is an Oncology physician affiliated with Johns Hopkins University. OpenAlex indexes 367 publications with 12,541 citations (h-index 57).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 N Wolfe St
Baltimore, MD 212870005
Telephone
410-955-9434Registry record last updated 12 Oct 2015.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
44.4%Statin19.9%Atorvastatin Calcium46%Rosuvastatin Calcium28%Pravastatin Sodium18%Simvastatin7%Part D<11 patientsCalcium channel blocker5.5%Amlodipine Besylate100%Part D≥21 patients+ 6 more classes in this area
Nervous system
23.4%SSRI7%Sertraline Hcl42%Trazodone Hcl21%Escitalopram Oxalate20%Fluoxetine Hcl17%Part D<11 patientsGabapentinoids3.9%Gabapentin100%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
12.6%Proton pump inhibitor4.6%Omeprazole70%Pantoprazole Sodium30%Part D<11 patientsBiguanide (metformin)3.3%Metformin Hcl61%Metformin Hcl Er39%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
9 NIH research awards on record, funded 2002–2024 per NIH RePORTER. The latest:
- PRAGMATIC TRIAL TO IMPROVE COMMUNICATION FOR PRIMARY CARE PATIENTS WITH ADRD
Johns Hopkins University
FY2022$1,083,680R33AG061882
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- <p>Analysis of Patient Preferences in Lung Cancer – Estimating Acceptable Tradeoffs Between Treatment Benefit and Side Effects</p>
Patient Preference and Adherence
2020 - Does Caregiving Strain Increase as Patients With and Without Dementia Approach the End of Life?
Journal of Pain and Symptom Management
2018 - Older Adults’ Views and Communication Preferences About Cancer Screening Cessation
JAMA Internal Medicine
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Daniel Laheru, MD
Johns Hopkins University
Demosthenes G. Katritsis
Johns Hopkins University
Tanguy Seiwert, MD
Johns Hopkins University
Evan Lipson, MD
Johns Hopkins University
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”